Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. - Wikidata - awgldk - TriplyDB

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

http://www.wikidata.org/entity/Q36194321

about

Circulating miR-499 as a potential biomarker for acute myocardial infarction MicroRNAs in the Stressed Heart: Sorting the Signal from the Noise Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype Heart failure: advanced development in genetics and epigenetics Epigenetic mechanisms in heart development and disease Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Non-coding RNAs in cardiac hypertrophy.MicroRNAs expression profiles in cardiovascular diseases.Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.Deep sequencing of cardiac microRNA-mRNA interactomes in clinical and experimental cardiomyopathy.MicroRNAs and Cardiac Regeneration Heart Failure in Chronic Myocarditis: A Role for microRNAs?A human 3' miR-499 mutation alters cardiac mRNA targeting and function.Postnatal β-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning.Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation.Regulation of cardiac microRNAs by cardiac microRNAs.A genome-wide association study of congenital cardiovascular left-sided lesions shows association with a locus on chromosome 20.Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.Insights into RNA transcriptome profiling of cardiac tissue in obesity and hypertension conditions.Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.Epitranscriptional regulation of cardiovascular development and disease.Transcriptional regulatory circuits controlling muscle fiber type switching.MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.Harnessing fetal and adult genetic reprograming for therapy of heart disease.Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.Role of microRNA in metabolic shift during heart failure.Role of microRNAs in cardiac development and disease.Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a.let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3.Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy.Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNA.

P2860

Q26750940-54FF8412-6C2B-4DDB-B7B6-8F753FF57412 Q26995334-220A35A7-5F95-4536-B33C-90084B270A86 Q28066435-9C9DCA27-EC79-47F5-B39E-77C79AFD9B85 Q28080771-C2417517-07CE-4458-858F-85DD59B39516 Q28081134-E7FF3724-13E5-49A0-90EA-8EA1B932676D Q28384038-5C4AE93F-FB28-42FE-A1C6-7A4E999FCAC3 Q28395675-47B63C7B-1F79-4320-8912-3EAB9987DC26 Q33800147-FC86396B-D28C-4968-B897-79D203A353F4 Q33821302-BE1AA1B9-D9B2-4BDD-ADA3-D38C36C57CEB Q33822186-4D5C397F-5488-46F9-9305-45B975193241 Q34082965-8AC3E11E-E8B1-4BCE-96CC-8127D92A2AD9 Q34356918-55A7C427-65D5-4465-B11D-0B430A5E9823 Q34776341-983B0DEE-860E-4910-8AF2-F7D9254D25EB Q35593966-0BD46243-03E0-4B47-9158-D0FC2891C1F7 Q35597374-62021EF8-90E1-4E88-B008-D72C66D4A7BE Q35742151-2E703F54-43BA-48A4-9E2E-7C6788828064 Q35873898-EA98793B-5B3B-466D-92B3-C85FE654F80F Q36059303-EAFE5C90-B4B5-4C20-BACE-75C61CA9C3AC Q36378208-01B83F68-D514-42DE-A4AF-F1C2C13D0FF7 Q36917391-36C0C093-F173-42E2-B269-D32DA8FB3BF2 Q37010179-FB258ED6-1291-4098-8FC8-18D2C51C7301 Q37162692-57A7F336-52F0-47DC-9FC4-2CE000E50943 Q37367970-0665DAAA-80C9-4E75-96BB-CFB5E49EFA99 Q37685243-108C3067-4DAA-4C1D-9858-92091A98DFFE Q38267844-9015C8F1-A7AC-4660-B407-5ABDC3FD0135 Q38272306-EE34FDAC-A6C1-4152-B8DE-57DF2B17D5E5 Q38272573-653037B2-1230-46DF-8E7A-A0484D2401E1 Q38385739-908068A8-2B15-406F-8632-0510836BA550 Q38404768-6135112F-212A-4D32-9C6F-99CC4239362C Q38423287-58953BC6-D5EF-4267-9232-1155EDBA130B Q38559081-2F4995FC-9D72-4335-BFC9-605EDD57D81D Q38591803-8B94862F-25DC-446C-9488-5FC7547733A5 Q38888119-C90B6D50-D93D-4675-B9B5-C6A521C8325E Q38981243-73F81876-A56D-40C1-9B46-F24A383360AE Q39103670-0C6CF854-E22A-446B-835F-F89533FD26C1 Q39172914-F5DD8F2F-882D-4489-B257-9D2AA65CDF29 Q40618751-0844EE2F-20A9-41B3-8B9A-44E9945249C2 Q42275401-78DB7F85-C8A4-4D08-951D-F9A8A7FE2080 Q42677237-5666FB5D-94A4-4FF2-86FF-79D1673082F3 Q42873479-F3A0A085-92BA-4D80-B79F-2FAB86D8D958

P2860

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

http://www.wikidata.org/entity/Q36194321

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@ast

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@en

type

label

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@ast

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@en

prefLabel

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@ast

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@en

P1433

Q36194321-1D7B85B7-2700-41F9-A980-581EC82F9F00

P1476

Q36194321-DC44085A-C551-49E7-98C3-F5E1D4DA6095

P2093

Q36194321-30B911D1-D5F3-425D-8969-C769403BA554

Q36194321-6225C0F5-B099-44E8-B1FE-F3E3C4082F5E

Q36194321-8C1BFB81-91AC-4336-97C7-5337C1FCDCED

Q36194321-D0FC8FB1-24BE-40D9-8A1C-BD4B2BE9F6B9

Q36194321-E9A4084A-26D0-436B-AF28-A89DF1D5EA9D

P2860

Q36194321-08398B3F-34FC-4D4B-9952-69A610D50EA3

Q36194321-0BE42048-917B-43D3-AFFC-9350BCFDEA1E

Q36194321-0D01DA9E-2F56-451D-9F6F-A44621A54EF9

Q36194321-0D34F106-BC20-4A09-BD4D-0F5C7FFD6809

Q36194321-0D52505F-1DFC-416B-99F8-8D56E8F5BEF1

Q36194321-15B8E2CE-177F-4489-94E7-92870509E3CC

Q36194321-182EA5EF-FEDE-47DE-A578-93AD67AADC91

Q36194321-20A10000-2666-4DE7-8AFA-1BB26972DF4E

Q36194321-21D2A1C9-686A-4F15-B112-A166E730157C

Q36194321-30093CD8-703B-4071-9325-D2A2584E194C

P304

Q36194321-21DA7ED5-80A2-4E8B-85CE-88A750E15B7D

P31

Q36194321-764E0855-7CCF-4A92-B42E-5D2134312DB0

P356

Q36194321-53F9691F-69E0-4568-A3DA-371433A7FBAE

P433

Q36194321-5B5866A1-2A97-4A87-A25E-4BF70D251D5C

P478

Q36194321-D32C20C5-0B43-42A3-88D1-AFDB3268AC4E

P577

Q36194321-7955087E-BA14-4EDE-8F8E-23915F90DE63

P698

Q36194321-A0DC07D3-B924-42BE-BBC1-6AE8D7430F65

P921

Q36194321-1CAD3416-0C0C-4735-B357-5E6279909E1F

P932

Q36194321-6F94A0F5-0BAF-41C0-9564-CD5578C12140

P356

CIRCRESAHA.112.265736

P1433

Circulation Research

P1476

Direct and indirect involvemen ...... d experimental cardiomyopathy.

@en

P2093

Gerald W Dorn

http://www.w3.org/2001/XMLSchema#string

Lisa E Dorn

http://www.w3.org/2001/XMLSchema#string

Scot J Matkovich

http://www.w3.org/2001/XMLSchema#string

William H Eschenbacher

http://www.w3.org/2001/XMLSchema#string

Yuanxin Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Mapping and quantifying mammalian transcriptomes by RNA-Seq

Regulation of cellular metabolism by protein lysine acetylation

Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex

Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes

Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs

The impact of microRNAs on protein output

RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays

Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers

P304

521-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.112.265736

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22752967

http://www.w3.org/2001/XMLSchema#string

P921

P932

3429338

http://www.w3.org/2001/XMLSchema#string